|
Volumn 327, Issue 7422, 2003, Pages 1003-1004
|
Treatment of postnatal depression
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIDEPRESSANT AGENT;
ESTROGEN;
FLUOXETINE;
HERBACEOUS AGENT;
NORTRIPTYLINE;
PAROXETINE;
PLACEBO;
SERTRALINE;
VENLAFAXINE;
BEHAVIOR THERAPY;
BRAIN DEVELOPMENT;
BREAST FEEDING;
CHILDBIRTH;
CLINICAL FEATURE;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
COGNITIVE DEVELOPMENT;
COGNITIVE THERAPY;
CONTROLLED CLINICAL TRIAL;
DIAGNOSTIC ACCURACY;
DIAGNOSTIC ERROR;
DISEASE COURSE;
DRUG EFFECT;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
EDITORIAL;
ESTROGEN ACTIVITY;
EVALUATION;
FEEDING DISORDER;
FOLLOW UP;
HERBAL MEDICINE;
HUMAN;
HYPERICUM PERFORATUM;
IRRITABILITY;
MASSAGE;
MENTAL INSTABILITY;
MOTHER CHILD RELATION;
OUTCOMES RESEARCH;
PATIENT COUNSELING;
PHOTOTHERAPY;
PREVALENCE;
PRIMARY MEDICAL CARE;
PRIORITY JOURNAL;
PSYCHODYNAMICS;
PSYCHOTHERAPY;
PUERPERAL DEPRESSION;
RANDOMIZED CONTROLLED TRIAL;
RATING SCALE;
RELAXATION TRAINING;
SCREENING TEST;
SIDE EFFECT;
SLEEP DISORDER;
SOCIAL EVOLUTION;
SYMPTOM;
TECHNIQUE;
|
EID: 0242383453
PISSN: 09598146
EISSN: None
Source Type: Journal
DOI: 10.1136/bmj.327.7422.1003 Document Type: Editorial |
Times cited : (39)
|
References (12)
|